Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 8, 2010, Pages 1141-1145

  Chen, Wei Ping ^a   Bao, Jia Peng ^a   Feng, Jie ^a   Hu, Peng Fei ^a   Shi, Zhong Li ^a   Wu, Li Dong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

joint tissues; osteoarthritis; serum; synovial fluid; visfatin

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AGED; AMPUTATION; ARTHROCENTESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JOINT; KNEE OSTEOARTHRITIS; MALE; OSTEOPHYTE; PATELLA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SYNOVIAL FLUID; SYNOVIUM; TISSUE CULTURE; TOTAL KNEE REPLACEMENT;

AGED; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOARTHRITIS; OSTEOPHYTE; SYNOVIAL FLUID;

EID: 77955458272     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.230     Document Type: Article

References (29)

1. Kitani T, Okuno S, Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colonyenhancing factor. FEBS Lett 2003;544:74-78
2. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;14: 1431-1437
3. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, et. al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004;113:1318-1327
4. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, et. al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005;185:R1-8.
5. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, et. al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005;289:E586-90.
6. Hufton SE, Moerkerk PT, Brandwijk R, de Bruine AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 1999;463:77-82.
7. Ye SQ, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, et. al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005;171:361-370
8. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et. al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-430
9. Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A, et. al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007;115:972-980
10. Adya R, Tan BK, Chen J, Randeva HS. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis 2009;205:113-119
11. Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, et. al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 2007;56: 2829-2839
12. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colonyenhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002;187:1051-1058
13. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, et. al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178:1748-1758
14. Pottie P, Presle N, Terlain B, Netter P, Mainard D, BerenbaumF. Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis 2006;65:1403-1405
15. Aspden RM, Scheven BA, Hutchison JD. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001;357:1118-1120
16. Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 2006;1762:711-718
17. Lee JH, Ort T, Ma K, Picha K, Carton J, Marsters PA, et. al. Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro. Osteoarthr Cartilage 2009;17:613-620
18. Gosset M, Berenbaum F, Salvat C, Sautet A, Pigenet A, Tahiri K, et. al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 2008;58:1399-1409
19. Nowell MA, Richards PJ, Fielding CA, Ognjanovic S, Topley N, Williams AS, et. al. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2006;54:2084-2095
20. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, et. al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1198-1201
21. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et. al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-1049
22. Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S, et. al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthr Cartilage 2006;14:690-695
23. Cooper C, Snow S, McAlindon TE, Kellingray S, Stuart B, Coggon D, et. al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000;43:995-1000.
24. Schouten JS, van den Ouweland FA, Valkenburg HA. A 12- year follow-up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 1992;51:932-937
25. Davis MA, Neuhaus JM, Ettinger WH, Mueller WH. Body fat distribution and osteoarthritis. Am J Epidemiol 1990;132:701-707
26. Sharma L, Lou C, Cahue S, Dunlop DD. The mechanism of the effect of obesity in knee osteoarthritis: The mediating role of malalignment. Arthritis Rheum 2000;43:568-575
27. Gabay O, Hall DJ, Berenbaum F, Henrotin Y, Sanchez C. Osteoarthritis and obesity: experimental models. Joint Bone Spine 2008;75:675-679
28. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, et. al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009;60: 1906-1914
29. Shine B, Bourne JT, Begum Baig F, Dacre J, Doyle DV. Creactive protein and immunoglobulin G in synovial fluid and serum in joint disease. Ann Rheum Dis 1991;50:32-35